321 related articles for article (PubMed ID: 21576701)
1. Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders.
Piconi S; Parisotto S; Rizzardini G; Passerini S; Terzi R; Argenteri B; Meraviglia P; Capetti A; Biasin M; Trabattoni D; Clerici M
Blood; 2011 Sep; 118(12):3263-72. PubMed ID: 21576701
[TBL] [Abstract][Full Text] [Related]
2. Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy.
Massanella M; Bakeman W; Sithinamsuwan P; Fletcher JLK; Chomchey N; Tipsuk S; Chalermchai T; Routy JP; Ananworanich J; Valcour VG; Chomont N
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597764
[TBL] [Abstract][Full Text] [Related]
3. Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection.
Naidoo KK; Ndumnego OC; Ismail N; Dong KL; Ndung'u T
Front Immunol; 2021; 12():738743. PubMed ID: 34630420
[TBL] [Abstract][Full Text] [Related]
4. Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy.
Piconi S; Trabattoni D; Gori A; Parisotto S; Magni C; Meraviglia P; Bandera A; Capetti A; Rizzardini G; Clerici M
AIDS; 2010 Aug; 24(13):1991-2000. PubMed ID: 20651586
[TBL] [Abstract][Full Text] [Related]
5. Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery.
Stiksrud B; Aass HCD; Lorvik KB; Ueland T; Trøseid M; Dyrhol-Riise AM
AIDS; 2019 Jun; 33(7):1117-1129. PubMed ID: 30789356
[TBL] [Abstract][Full Text] [Related]
6. Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
Routy JP; Angel JB; Patel M; Kanagaratham C; Radzioch D; Kema I; Gilmore N; Ancuta P; Singer J; Jenabian MA
HIV Med; 2015 Jan; 16(1):48-56. PubMed ID: 24889179
[TBL] [Abstract][Full Text] [Related]
7. Frontline Science: CXCR7 mediates CD14
Veenstra M; Williams DW; Calderon TM; Anastos K; Morgello S; Berman JW
J Leukoc Biol; 2017 Nov; 102(5):1173-1185. PubMed ID: 28754798
[TBL] [Abstract][Full Text] [Related]
8. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
Gray CM; Schapiro JM; Winters MA; Merigan TC
AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
[TBL] [Abstract][Full Text] [Related]
9. Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells.
Horta A; Nobrega C; Amorim-Machado P; Coutinho-Teixeira V; Barreira-Silva P; Boavida S; Costa P; Sarmento-Castro R; Castro AG; Correia-Neves M
PLoS One; 2013; 8(2):e57336. PubMed ID: 23437372
[TBL] [Abstract][Full Text] [Related]
10. Decrease in immune activation in HIV-infected patients treated with highly active antiretroviral therapy correlates with the function of hematopoietic progenitor cells and the number of naive CD4+ cells.
Nielsen SD; Sørensen TU; Ersbøll AK; Ngo N; Mathiesen L; Nielsen JO; Hansen JE
Scand J Infect Dis; 2000; 32(6):597-603. PubMed ID: 11200367
[TBL] [Abstract][Full Text] [Related]
11. Impaired restoration of plasmacytoid dendritic cells in HIV-1-infected patients with poor CD4 T cell reconstitution is associated with decrease in capacity to produce IFN-alpha but not proinflammatory cytokines.
Sachdeva N; Asthana V; Brewer TH; Garcia D; Asthana D
J Immunol; 2008 Aug; 181(4):2887-97. PubMed ID: 18684980
[TBL] [Abstract][Full Text] [Related]
12. Poor functional immune recovery in aged HIV-1-infected patients following successfully treatment with antiretroviral therapy.
Kasahara TM; Hygino J; Andrade RM; Monteiro C; Sacramento PM; Andrade AF; Bento CA
Hum Immunol; 2015 Oct; 76(10):701-10. PubMed ID: 26429325
[TBL] [Abstract][Full Text] [Related]
13. Role of in vitro stimulation with lipopolysaccharide on T-cell activation in HIV-infected antiretroviral-treated patients.
Tincati C; Bellistrì GM; Ancona G; Merlini E; d'Arminio Monforte A; Marchetti G
Clin Dev Immunol; 2012; 2012():935425. PubMed ID: 22400042
[TBL] [Abstract][Full Text] [Related]
14. HIV DNA and immune alteration during successful HAART.
Mamadou D; Yu-Huang Z; Xia C; Bo H; Hua-Ying Z; Yan H; Zi C; Qing L; Li-Wen Z; Mei H; Yun-Hai Y; Demba S; Aldebert D; Souleymane M
Curr HIV Res; 2013 Jun; 11(4):255-62. PubMed ID: 23822818
[TBL] [Abstract][Full Text] [Related]
15. Plasticity of the Immune System in Children Following Treatment Interruption in HIV-1 Infection.
Sandgaard KS; Margetts B; Attenborough T; Gkouleli T; Adams S; Holm M; Gibb D; Gibbons D; Giaquinto C; De Rossi A; Bamford A; Palma P; Chain B; Gkazi AS; Klein N
Front Immunol; 2021; 12():643189. PubMed ID: 34475868
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV type 1 replication in CD4+ and CD14+ cells purified from HIV type 1-infected individuals by the 2-5A agonist immunomodulator, 2-5A(N6B).
Dimitrova DI; Reichenbach NL; Yang X; Pfleiderer W; Charubala R; Gaughan JP; Suh B; Henderson EE; Suhadolnik RJ; Rogers TJ
AIDS Res Hum Retroviruses; 2007 Jan; 23(1):123-34. PubMed ID: 17263642
[TBL] [Abstract][Full Text] [Related]
17. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation.
Patro SC; Azzoni L; Joseph J; Fair MG; Sierra-Madero JG; Rassool MS; Sanne I; Montaner LJ
J Leukoc Biol; 2016 Jul; 100(1):223-31. PubMed ID: 26609048
[TBL] [Abstract][Full Text] [Related]
19. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.
Kaufmann GR; Zaunders JJ; Cunningham P; Kelleher AD; Grey P; Smith D; Carr A; Cooper DA
AIDS; 2000 Dec; 14(17):2643-51. PubMed ID: 11125882
[TBL] [Abstract][Full Text] [Related]
20. Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.
Evans TG; Bonnez W; Soucier HR; Fitzgerald T; Gibbons DC; Reichman RC
Antiviral Res; 1998 Oct; 39(3):163-73. PubMed ID: 9833957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
